Unicycive Therapeutics, Inc.
UNCY
$5.12
$0.091.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.22M | -39.95M | -26.56M | -33.41M | -31.50M |
| Total Depreciation and Amortization | 661.00K | 648.00K | 572.00K | 555.00K | 530.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.64M | 13.97M | 620.00K | 5.22M | 4.40M |
| Change in Net Operating Assets | -1.92M | -3.32M | -5.95M | -2.19M | -6.56M |
| Cash from Operations | -27.84M | -28.66M | -31.32M | -29.83M | -33.12M |
| Capital Expenditure | -9.00K | -16.00K | -24.00K | -46.00K | -68.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.24M | -17.22M | -12.07M | -- | -- |
| Cash from Investing | -17.25M | -17.23M | -12.10M | -46.00K | -68.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 69.02M | 65.46M | 48.08M | 41.95M | 14.80M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 0.00 | 0.00 |
| Other Financing Activities | -2.07M | -1.97M | -1.61M | -1.72M | -1.07M |
| Cash from Financing | 66.95M | 63.49M | 46.47M | 40.23M | 13.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.86M | 17.60M | 3.06M | 10.35M | -19.45M |